Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis-Reference-Cited by-同舟云学术

Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis

Published:2016 Issue:4 Volume:56 Page:170-179
ISSN:0470-8105
Container-title:Neurologia medico-chirurgica
language:en
Short-container-title:Neurol. Med. Chir.(Tokyo)

Author:

OHBA Shigeo¹,HIROSE Yuichi¹

Affiliation:

1. Department of Neurosurgery, Fujita Health University

Publisher

Japan Neurosurgical Society

Subject

Neurology (clinical),Surgery

Link

https://www.jstage.jst.go.jp/article/nmc/56/4/56_ra.2015-0322/_pdf

Reference48 articles.

1. 1) Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO Classification of Tumors of the Central Nervous System, ed 4. International agency for research on cancer, Lyon

2. 2) Ichimura K, Narita Y, Hawkins CE: Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers. Acta Neuropathol 129: 789–808, 2015

3. 3) Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P; International Society Of Neuropathology—Haarlem: International Society Of Neuropathology—Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24: 429–435, 2014

4. 4) Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW: An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807–1812, 2008

5. 5) Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A: Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118: 469–474, 2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis;BMC Medicine;2023-12-05

2. Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma;Cancers;2023-02-02

3. A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma;Frontiers in Neurology;2022-12-14

4. Prognostic Estimation Model for Oligodendroglioma: An mRNA-Sequence Data-Based Analysis;2022-08-19

5. Systematic Review of Epigenetic Therapies for Treatment of IDH-mutant Glioma;World Neurosurgery;2022-06